Allelica, a precision medicine company focused on genomic risk assessment for common diseases, today announced that it has entered into a commercial license agreement with Cambridge Enterprise, the ...
Cardiovascular disease (“CVD”) is the leading cause of death in the US and worldwide with over 82 million Americans living with CVD. CVD accounts for one in every three deaths in the US, or more than ...
An international expert group has published the first evidence-based clinical guidance on the use of polygenic risk scores (PRSs) for breast cancer. Published in the peer-reviewed journal Cancers, the ...
Polygenic background bidirectionally modifies the penetrance of pathogenic variants in hypertrophic (HCM) and dilated (DCM) ...
Patients who learn their likelihood of developing CAD not only from the Framingham Risk Score but also from a more-personalized polygenic risk score experience fewer major adverse cardiovascular ...
USA: Researchers have discovered in a new research that bronchodilator responsiveness (BDR) shows a stronger association with ...
Rhythm Biosciences Ltd ('RHY', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated ...
The addition of polygenic risk scores (PRS) improved the accuracy of the cardiovascular disease (CVD) risk prediction tool PREVENT across all groups studied, across ancestries. Over 3 million people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback